Spontaneous bacterial peritonitis

Seminars in Liver Disease

Volumn 17, Issue 3, 1997, Pages 203-217

  Guarner, Carlos ^a   Soriano, Germán ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Ascites; Cirrhosis; Selective intestinal decontamination; Spontaneous bacterial peritonitis

Indexed keywords

ASCITES; ASCITES FLUID ANALYSIS; BACTERIAL INFECTION; BACTERIAL PERITONITIS; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; HIGH RISK POPULATION; HUMAN; LIVER CIRRHOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REVIEW;

EID: 0030922914     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007198     Document Type: Review

References (134)

1. Hoefs JC, Runyon BA. Spontaneous bacterial peritonitis. Disease-a-Month 31:1-48, 1985.
2. Conn HO. Spontaneous peritonitis and bacteremia in Laennec's cirrhosis caused by enteric organisms. Ann Intern Med 60:568-80, 1964.
3. Thomas FB, Fromkes JJ. Spontaneous bacterial peritonitis associated with acute viral hepatitis. J Clin Gastroenterol 4:259-62, 1982.
4. Barness LA, Moll GH, Janeway CA. Nephrotic syndrome: natural history of the disease. Pediatrics 5:486-503, 1950.
5. Runyon BA. Spontaneous bacterial peritonitis associated with cardiac ascites. Am J Gastroenterol 79:796, 1984.
6. Kurtz RC, Bronzo RL. Does spontaneous bacterial peritonitis occur in malignant ascites? Am J Gastroenterol 77:146-8, 1982.
7. Hoefs JC, Canawatti HN, Sapico FL, et al. Spontaneous bacterial peritonitis. Hepatology 2:399-407, 1982.
8. Pinzello G, Simonetti RG, Craxi A, et al. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic patients. Hepatology 3:545-9, 1983.
9. Almdal TP, Skinhoj P. Spontaneous bacterial peritonitis in cirrhosis. Incidence, diagnosis and prognosis. Scand J Gastroenterol 22:295-300, 1987.
10. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis J Hepatol 21 792-6, 1994.
11. Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4:53-8, 1984.
12. Runyon BA, Morrissey RL, Hoefs JC, Wyle FA. Opsonic activity of human ascitic fluid a potentially important mechanism against spontaneous bacterial peritonitis. Hepatology 5:634-7, 1985.
13. Runyon BA. Spontaneous bacterial peritonitis' an explosion of information. Hepatology 8:171-5, 1988.
14. Llovet JM, Planas R, Morillas R, et al. Short-term prognosis of cirrhotic patients with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 88:388-92, 1993
15. Toledo C, Salmeron JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 17:251-7, 1993.
16. Rimola A, Navasa M, Arroyo V. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Diagn Microbiol Infect Dis 22:141-5, 1995.
17. Runyon BA, McHutchison JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 100:1737-42, 1991.
18. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 18:271-2, 1993.
19. Tito L, Rimola A, Gines P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 8:27-31, 1988.
20. Silvain C, Besson I, Ingrand P, et al. Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis. J Hepatol 19:188-9, 1993.
21. Andreu M, Sola R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 104:1133-8, 1993.
22. Altman C, Grange J-D, Amiot X, et al. Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation. J Gastro Hepatol 10:47-50, 1995
23. Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 103:1267-72, 1992.
24. Soriano G, Guarner C, Teixido M, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 100:477-81, 1991.
25. Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 12:716-24, 1990.
26. Guarner C, Runyon BA Spontaneous bacterial peritonitis: Pathogenesis, diagnosis, and management. Gastroenterologist 3:311-28, 1995.
27. Runyon BA. Bacterial infections in patients with cirrhosis. J Hepatol 18:271-2, 1993.
28. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 91:1343-6, 1986.
29. Such J, Guarner C, Enriquez J, et al. Low C3 in ascitic fluid predisposes to spontaneous bacterial peritonitis. J Hepatol 6:80-4, 1988.
30. Rabinovitz M, Gavaler JS, Kumar S, et al. Role of serum complement, immunoglobulins, and cell-mediated immune system in the pathogenesis of spontaneous bacterial peritonitis (SBP). Dig Dis Sci 34:1547-52, 1989.
31. Bolognesi M, Merkel C, Bianco S, et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 19:628-34, 1994.
32. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing, and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 6:252-62, 1986.
33. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 8:632-5, 1988.
34. Runyon BA, Borzio M, Young S, et al. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 21:1719-24, 1995.
35. Runyon BA. Fatal bacterial peritonitis secondary to nonobstructive colonic dilatation (Ogilvie's syndrome) in cirrhotic ascites. J Clin Gastroenterol 8 687-9, 1986.
36. Berg RD. Bacterial translocation from the gastrointestinal tract. J Med 23:217-44, 1992.
37. Llovet JM, Bartoli R, Planas R, et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 35:1648-52, 1994.
38. Garcia-Tsao G, Lee F-Y, Barden GE, et al. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 108:1835-41, 1995.
39. Deitch EA, Morrison J, Berg R, Specian RD. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. CritCare Med 18:529-36, 1990.
40. Deitch EA, Sittig K, Li M, et al. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 159:79-84, 1988.
41. Llovet JM, Bartoli R, March F, et al. DNA fingerprinting demonstrates that spontaneous bacterial peritonitis is mainly due to translocating bacteria of gut origin. Hepatology 22:A166, 1995.
42. Sedman B, MacFie J, Sagar P, et al. The prevalence of gut translocation in humans. Gastroenterology 107:643-9, 1994.
43. Balthazar EJ, Gade MF. Gastrointestinal edema in cirrhotics. Gastrintest Radiol 1:215-23, 1976.
44. Sorell WT, Quigley EMM, Jin G, et al. Bacterial translocation in the portal-hypertensive rat: Studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology 104: 1722-6, 1993.
45. Garcia-Tsao G, Albillos A, Barden GE. West AB. Bacterial translocation in acute and chronic portal hypertension. Hepatology 17:1081-5, 1993.
46. Deitch EA, Specian RD, Berg RD. Endotoxin-induced bacterial translocation and mucosal permeability: Role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med 19:785-91, 1991.
47. Morrison DC, Ryan JL. Bacterial endotoxins and host immune responses. Adv Immunol 28:293-450, 1979.
48. Guarner C, Soriano G, Tomas A, et al. Increased serum nitrite and nitrate in patients with cirrhosis of the liver: relationship to endotoxemia Hepatology 18:1139-43, 1993.
49. Martini GA, Phear EA, Ruebner B, Sherlock S. The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity. Clin Sci 16:35-51, 1957.
50. Chesta J, Silva M, Thompson L, et al. Small intestinal bacterial overgrowth in patients with hepatic cirrhosis. Rev Med Chil 119:626-32, 1991.
51. Casafont F, de las Heras G, Martin L, et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 40:1252-6, 1995.
52. Guarner C, Runyon BA, Young S, et al. Intestinal bacterial overgrowth and bacterial translocation in an experimental model of cirrhosis in rats. J Hepatol 26:1372-8, 1997.
53. Young L, Martin B, Meyer R, et al. Gram-negative rod bacteremia: microbiologic, immunologic and therapeutic considerations Ann Intern Med 86:456-71, 1977.
54. Schifferli JA, Ng CN, Peters DK. The role of complement and its receptor in the elimination of immune complexes. N Eng J Med 315:486-95, 1986.
55. Gomez P, Ruiz P, Schreiber AD. Impaired function of macrophage Fc-gamma receptors and bacterial infection in alcoholic cirrhosis. N Eng J Med 331:1122-8, 1994.
56. Nilsson Ekdahl K, Loof L, Nyberg A, et al. Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis. Gastroenterology 101:1076-82, 1991.
57. Dunn DL, Barke RA, Knight NB, et al. Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infec Immun 49:257-64, 1985.
58. McHutchison JG, Runyon BA. Spontaneous bacterial peritonitis. In. Surawicz CM, Owen RL, (eds): Gastrointestinal and Hepatic Infections. Philadelphia: W.B. Saunders, 1994, 455-475.
59. Runyon BA, Hoefs JC Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 4:1209-11, 1984.
60. Pelletier G, Salmon D, Ink O, et al. Culture-negative neutrocytic ascites: A less severe variant of SBP. J Hepatol 10:327-31, 1990.
61. al Amri SM, Allam AR, al Mofleh IA. Spontaneous bacterial peritonitis and culture negative neutrocytic ascites in patients with non-alcoholic liver cirrhosis. J Gastroenterol Hepatol 9:433-6, 1994.
62. Terg R, Levi D, Lopez P, et al Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites. Evidence of the same disease. Dig Dis Sci 37:1499-1504, 1992.
63. Pelletier G, Lesur G, Ink O, et al. Asymptomatic bacterascites: is it spontaneous bacterial peritonitis? Hepatology 14:112-5, 1991.
64. Chu Ch-M, Chang K-Y, Liaw Y-F. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites. Dig Dis Sci 40:561-5, 1995.
65. Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology 4:447-50, 1984.
66. Akriviadis EA, Runyon BA. The value of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 98:127-33, 1990.
67. Runyon BA, Canawatti HN, Hoefs JC. Polymicrobial bacterascites: a unique entity in the spectrum of infected ascitic fluid. Arch Intern Med 146:2173-5, 1986.
68. Xiol X, Castellvi JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 23:719-23, 1996.
69. Yoshida H, Hamada T, Inuzaka S, et al. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol 88:2067-71, 1993
70. Rimola A, Bory F, Teres J, et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 5:463-7, 1985.
71. Bleichner G, Boulanger R, Squara P, et al. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 73:724-6, 1986.
72. Carr F, Loegering D. Reticuloendothelial system function and humoral deficiency following acute haemorrhage. Can J Physiol 56:299-303, 1978.
73. Hamdani R, Young S, Runyon BA. Increased bacterial translocation in cirrhotic rats undergoing hemorrhagic shock. Gastroenterology 104:A904, 1994.
74. Llovet JM, Bartoli R, Planas R, et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 23:781-7, 1996.
75. Wang SS, Tsai YT, Lee SD, et al Spontaneous bacterial peritonitis in patients with hepatitis B-related cirrhosis and hepatocellular carcinoma. Gastroenterology 101:1656-62, 1991.
76. Carey WD, Boayke A, Leatherman J. Spontaneous bacterial peritonitis: clinical and laboratory features with reference to hospital acquired cases. Am J Gastroenterol 81:1156-61, 1986
77. Ho H, Zuckerman MJ, Wassem C. A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices Gastroenterology 101:1642-8, 1991.
78. Bac DJ, de Marie S, Siersema PD, et al. Post-sclerotherapy bacterial peritonitis: a complication of sclerotherapy or of variceal bleeding? Am J Gastroenterol 89:859-62, 1994.
79. Rolando N, Gimson A, Philpott-Howard J, et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol 18:290-4, 1993.
80. Selby WS, Norton ID, Pokorny ChS, Bernn RAV. Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial. Gastrointest Endosc 40:680-4, 1994.
81. Goff JS, Reveille RM, Stiegmann GV. Endoscopic sclerotherapy versus endoscopic variceal ligation: esophageal symptoms, complications, and motility. Am J Gastroenterol 83:1240-4, 1988.
82. Laine L, El-Newihi HM, Migicovsky, et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 119:1-7, 1993.
83. Lo G-H, Lai K-H, Shen M-T, Chang Ch-F. A comparison of the incidence of transient bacteremia and infectious sequelac after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc 40:675-9, 1994.
84. Conn HO. Bacterial peritonitis, spontaneous or paracentetic? Gastroenterology 77:1145-6, 1979.
85. Runyon BA. Paracentesis of ascitic fluid: a safe procedure. Arch Intern Med 146:2259-61, 1986.
86. Runyon BA. Care of patients with ascites. N Eng J Med 330:337-42, 1994.
87. Runyon BA, Antillen MR, Montano AA. Effect of diuresis versus therapeutic paracentesis on ascitic fluid opsonic activity and serum complement. Gastroenterology 97:158-62, 1989.
88. Ljubicic N, Bilic A, Kopjar B. Diuretics vs. paracentesis followed by diuretics in cirrhosis: effect on ascites opsonic activity and immunoglobulin and complement concentrations. Hepatology 19:346-53, 1994.
89. Sola R, Andreu M, Coll S, et al. Spontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: results of a randomized study. Hepatology 21:340-4, 1995.
90. Ho H, Zuckerman MJ, Ho TK, et al. Prevalence of associated infections in community-acquired spontaneous bacterial peritonitis. Am J Gastroenterol 91:735-42, 1996.
91. Romero A, Pérez-Arellano JL, Gonzalez-Villarón L, et al. Effect of transferrin concentration on bacterial growth in human ascitic fluid from cirrhotic and neoplastic patients. Eur J Clin Invest 23:699-705, 1993.
92. Runyon BA, Canawatti HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 95:1351-5, 1988.
93. Votte Lambert A, Joly JP, Becuwe C, et al. Chlamydia trachomatis peritonitis: another cause of protein-rich lymphocytic ascites. J Clin Gastroenterol 12:341-3, 1990.
94. Hoefs JC. Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease. Hepatology 1:249-54, 1981.
95. Gitlin N, Stauffer JL, Silvestri RC The pH of ascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis. Hepatology 2:408-11, 1982
96. Garcia-Tsao G, Conn HO, Lerner E. The diagnosis of bacterial peritonitis: comparison of pH, lactate concentration and leukocyte count Hepatology 5:91-6, 1985
97. Yang ChY, Liaw YF, Chu ChM, Sheen IS. White count, pH and lactate in ascites in the diagnosis of spontaneous bacterial peritonitis. Hepatology 1:85-90, 1985
98. Albillos A, Cuervas-Mons V, Millan I, et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 98:134-40, 1990.
99. Runyon BA, Antillon MR. Ascitic fluid pH and lactate: insensitive and nonspecific tests in detecting ascitic fluid infection. Hepatology 13:929-35, 1991.
100. Propst T, Propst A, Herold M, et al. Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators. Eur J Clin Invest 23:832-6, 1993.
101. Zeni F, Tardy B, Vindimian M, et al. High levels of tumor necrosis factor-alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 17:218-23, 1993.
102. Le Moine O, Deviere J, Devaster J-M, et al. Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol 20:819-24, 1994.
103. Runyon BA, Umland ET, Merlin T. Inoculation of blood culture bottles with ascitic fluid: improved detection of spontaneous bacterial peritonitis. Arch Intern Med 147:73-5, 1987.
104. Castellote J, Xiol X, Verdaguer R, et al. Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis. Am J Gastroenterol 85:1605-8, 1990.
105. Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 28:2811-2, 1990.
106. Ortiz J, Soriano G, Coll P, et al. Early microbiologic diagnosis of spontaneous bacterial peritonitis with BacT/Alert. J Hepatol 26:839-44, 1997.
107. Cappell MS, Shetty V. A multicenter, case-controlled study of the clinical presentation and etiology of ascites and the safety and clinical efficacy of diagnostic abdominal paracentesis in HIV seropositive patients. Am J Gastroenterol 89:2172-7, 1994.
108. Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20: 1495-1501, 1994
109. Soriano G, Coll P, Guarner C, et al. Escherichia coli capsular polysaccharide and spontaneous bacterial peritonitis in cirrhosis. Hepatology 21:668-73, 1995.
110. Cabrera J, Arroyo V, Ballesta AM, et al. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta2-microglobulin to discriminate functional renal failure from acute tubular damage. Gatroenterology 82:97-105, 1982.
111. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 5:457-62, 1985.
112. Runyon BA, Akriviadis EA, Sattler FR, Cohen J. Ascitic fluid and serum cefotaxime and desacetyl-cefotaxime levels in patients treated for bacterial peritonitis. Dig Dis Sci 12:1782-6, 1991.
113. Fong T, Akriviadis EA, Runyon BA, Reynolds TB. Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis. Hepatology 9:423-6, 1989.
114. Rimola A, Salmeron JM, Clemente G, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Results of a prospective, randomized, multicenter study. Hepatology 21:674-9, 1995.
115. Mercader J, Gomez J, Ruiz J, et al. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy 35(suppl.2):23-6, 1989.
116. Gomez-Jimenez J, Ribera E, Gasser I, et al. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemther 37:1587-92, 1993.
117. Ariza J, Xiol X, Esteve M, et al. Aztreonam vs cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. Hepatology 14:91-8, 1991.
118. Grange JD, Amiot X, Grange V, et al. Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: A prospective study of twenty-seven cases in cirrhotic patients. Hepatology 11:360-4, 1990
119. Silvain Ch, Breux JP, Grollier G, et al. Les septicemies et les infections du liquide d'ascite du cirrhotique peuventeelles être traitees exclusivement par voie orale?. Gastroenterol Clin Biol 13:335-9, 1989.
120. Navasa M, Planas R, Clemente G, et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 111:1011-7, 1996.
121. Castells A, Salo J, Planas R, et al. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study. Hepatology 20-584-91, 1994.
122. Runyon BA, VanEpps DE. Diuresis of ascites increases its opsonic activity and may prevent spontaneous bacterial peritonitis. Hepatology 6:369-99, 1986.
123. Runyon BA, Antillon MR, McHutchison JG. Diuresis increases ascitic fluid opsonic activity in patients who survive spontaneous bacterial peritonitis. J Hepatol 14:249-52, 1992.
124. van der Waaij D, Manson WL, Arends JP, de Vries Hospers HG. Clinical use of selective decontamination: the concept. Intensive Care Med 16(Suppl 3):S212-6, 1990.
125. van der Waaij D. Colonization resistence of the digestive tract: clinical consequences and implications. J Antimicrob Chemother 10:263-70, 1982.
126. Such J, Guarner C, Soriano G, et al. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis. Hepatology 12:1175-8, 1990.
127. Blaise M, Pateron D, Trinchet JC, et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 20:34-8, 1994.
128. Hoefs JC. Spontaneous bacterial peritonitis: prevention and therapy. Hepatology 12:776-81, 1990.
129. Schubert ML, Sanyal AJ, Wong ES. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis? Gastroenterology 101:550-2, 1991.
130. Novella MT, Sola R, Soriano A, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin Hepatology 25:532-6, 1997.
131. Grange JD, Roulot D, Pelletier G, et al. Primary prophylaxis of bacterial infections with norfloxacin in cirrhotic patients with ascites. Results of a double-blind, placebo-controlled trial. Gastroenterology 106:A901 (abstract), 1994.
132. Rolachon A, Cordier L, Bacq Y, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 22:1171-4, 1995.
133. Singh N, Gayowski T, Yu VL, Wagener MM. Trimethoprimsulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: A randomized trial. Ann Intern Med 122:595-8, 1995.
134. Ortiz J, Soriano G, Sola R, et al. Characteristics of the infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 22:166A, 1995.